Windtree Therapeutics launches a $200 million BNB treasury strategy

Windtree Therapeutics, a publicly traded biotechnology company on Nasdaq in the US, has announced plans to implement a crypto treasury strategy focused on $BNB , with a total potential investment of up to $200 million. The company has signed an investment agreement of $60 million with Build and Build Corp and may raise an additional $140 million.

Pioneering the BNB Treasury strategy in the US

The funds raised will be used to buy and hold BNB, build secure custodial infrastructure, and generate profits from this token. If approved by shareholders, #Windtree will become the first Nasdaq-listed company to directly own BNB, marking a "revolutionary" step according to CEO Jed Latkin.

Windtree's move is described by Patrick Horsman, CEO of Build and Build Corp, as "breakthrough and very timely," helping investors access Binance and BNB in a legitimate way. Binance founder Changpeng Zhao (CZ) also expressed excitement. Windtree's investment also includes stakes in Osprey BNB Chain Trust, a trust fund that allows investors to access BNB in the form of traditional securities.

Windtree believes that accumulating BNB will not only provide financial growth potential but also help the company enter the rapidly growing blockchain sector, especially as the regulatory environment in the US becomes more open. This trend is spreading, with YZi Labs and Nano Labs also actively buying BNB. Immediately following this news, Windtree's WINT stock price surged over 8.62%, and BNB also saw a slight increase of 3.4%, reaching $710. #anhbacong